Yatırımcı.AI

BISTTRY11:13Live

Eis Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş.

Eis Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş.ECILC

Star MarketChemicals, Petroleum, Rubber and Plastics
64.80−3.70 (−5.40%)
Volume
TRY 211.4M
Day range
63.20 – 68.30
Previous close
68.50
Market cap
TRY 44.4B

ECILC Ratio Analysis: P/E, P/B, EV/EBITDA

35 key ratios for Eis Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. (ECILC) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E—
P/B0.68
EV/EBITDA165.19
Dividend yield2.04%
Beta—
Earnings per share−2.8 TL
Book value per share100.4 TL
EBITDA−199.8M TL
Net profit−1.9B TL
Operating profit−215.6M TL
Operating profit before finance costs−895.5M TL
Net working capital2.5B TL
Gross margin37.83%
Operating margin−4.16%
Net margin−35.81%
Return on assets−2.50%
Return on equity−3.08%
Current ratio1.47
Quick ratio1.01
Cash ratio—
Leverage ratio18.92
Debt to equity0.23
Debt to assets0.19
Fixed assets to equity1.12
Short-term debt share0.04
Interest coverage—
Receivables turnover0.85
Days sales outstanding429
Inventory turnover1.32
Days inventory outstanding277
Payables turnover1.60
Days payables outstanding228
Working capital turnover2.08
Equity turnover0.08
Asset turnover0.06

Frequently asked questions

ECILC has a P/E ratio of —, a P/B ratio of 0.68 and an EV/EBITDA of 165.19.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.